Contact this trialFirst, we need to learn more about you.
Vasodilator
Nitric Oxide for Congenital Heart Defects
Recruiting1 awardPhase 2 & 3
Nashville, Tennessee
This trial will evaluate the neuro- and renal-protective effects of nitric oxide in patients undergoing surgery. GFAP and NGAL will be measured before and after surgery, and patients will be monitored for delirium, length of stay, and other outcomes.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service